New York – May 9, 2023 - Research Nester’s recent market research report on “Varicose Vein Treatment Market: Global Demand Analysis & Opportunity Outlook 2035” delivers a detailed competitor’s analysis and a detailed overview in terms of market segmentation by procedure, product, and by region.
Concerns about the Increasing Prevalence of Varicose Vein in the World to Promote Global Market Share of Varicose Vein Treatment
There is a considerable share of the global population who suffer from the occurrence of varicose veins. In the United States alone, the share of adults who suffer as a result of varicose veins is calculated to be 23%. Presently, an improvement has been observed in the compliance of patients toward the treatment methods. Patients following the treatment methods without failure are thought to be the major driving force behind the market growth for the treatments for varicose veins. High costs of the treatment methods often result in patients refraining from taking treatment for the health condition. However, several measures are being taken to ensure that the treatment for varicose veins is being followed well by the patients. Further, patients being able to access different methods and devices of treatment with ease should also contribute to the market growth.
Some of the major growth factors and challenges that are associated with the growth of the varicose vein treatment market are:
- Growing Preference for Surgical Methods Which Are Minimally Invasive
- Rapid Increase in the Research for Innovative Treatment Methods
There is a serious shortage in the number of surgeons who are skilled at dealing with vascular diseases. This dearth of skilled professionals is creating much anxiety among patients and healthcare institutes. Hence, the concerns regarding the lack of skills among health professionals to carry out the treatment procedure are thought to restrict the varicose vein treatment market growth to a great extent. Further, inconsistency in the reimbursement of treatment expenditure is anticipated to hamper the global market size of varicose vein treatment.
Access our detailed report on Varicose Vein Treatment Market Size & Share by Product (Ablation Devices, Sclerotherapy Injections); Procedure (Injection Sclerotherapy, Endovenous Ablation, Surgical Ligation) – Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035 @ https://www.researchnester.com/reports/novel-drug-delivery-systems-market/3930
By procedure, the varicose vein treatment market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation. Of these, the subsegment of injection sclerotherapy is expected to exhibit a significant growth rate during the forecast period. Several factors, such as the absence of anesthesia, fewer scars and bruises, reimbursement policies, short hospital stays, and ease of follow-up treatment, contribute to the demand for this treatment method for varicose veins. For instance, in the U.S., the patients who receive the injection sclerotherapy treatment for varicose veins could claim reimbursement under Medicare. Further, the increasing awareness about different treatment methods among patients should benefit the injection sclerotherapy method.
By region, the North American varicose vein treatment market is to generate the highest revenue by the end of 2035. The regional market is expected to hold a revenue share of ~34% by 2035. This growth is anticipated majorly as a result of a well-developed network of healthcare institutes in the United States. The nation also contributes largely to the disease burden in the region. Further, key players in the region benefit from simple government regulations for drug testing. The significant presence of the key players also makes new drugs and treatment methods more accessible to the patients in the region. Further effective reimbursement policies, which reduce the expense of the treatment, also contribute to the regional market growth.
This report also provides the existing competitive scenario of some of the key players of the varicose vein treatment market which includes company profiling of Candela Medical, Boston Scientific, Teleflex Incorporated, Biolitec AG (BioMed Technology Holdings Ltd), Alma Lasers Ltd, Sciton Inc., AngioDynamics Inc., Eufoton SRL, El. En SpA Group, Medtronic PLC, and others.